ASH Clinical News February 2016 | Page 71

FEATURE One reason for lingering concern is that the trialists set their own limits for what constitutes “fresh” and “old” RBC units – and there may never be a universal definition, Dr. Hébert said. “The definition of ‘fresh’ is different at different institutions,” he explained. “[In ABLE] we were pragmatic and set a limit ”The answer to the question of whether there is a difference between fresh and old blood seems to be an unequivocal ‘yes.’ ... But does it matter?” —JASON ZIMRING, MD, PhD of seven days for fresh blood, since it takes two days to get the blood into the hospital in the first place. For us, a week was fresh enough.” Though, he adds, setting a universal definition was not the goal of the trial. “What we really wanted to do was understand the clinical impact and outcomes.” What about focusing on the other end of the spectrum of blood freshness – deciding how old is too old? In other words, is there a point beyond which stored blood becomes ineffective or even harmful? The jury is still out on whether using blood at the extreme end of the storage cycle (up to or at 42 days) would have detrimental outcomes for transfusions, and it may be a while until the medical community gets those answers. Running a trial that tests old versus older or oldest blood would be problematic, Dr. Hébert said. “For me, old blood is over 30 days, but we still don’t know at what point blood gets ‘very old’ and potentially dangerous. To push the limit of that question in pa F